XTRA:FMEHealthcare
Fresenius Medical Care (XTRA:FME) Stock Rises On Margin Gains As Debt Risks Persist
Fresenius Medical Care went into this print with the stock up about 16% over three months and almost flat over the past month, a quiet setup for a company that just reported a sharp step up in profitability. The headline is not the top line; it is the margin story. Operating income climbed much faster than revenue, powered by a 180 basis point group margin expansion and supported by higher dialysis reimbursement and cost savings.
The emotional tug of a stock that has already re‑rated meets...